The consequences of requesting "dispense as written"

American Journal of Medicine

Volumn 124, Issue 4, 2011, Pages 309-317

  Shrank, William H ^a,b   Liberman, Joshua N ^c   Fischer, Michael A ^a   Avorn, Jerry ^a   Kilabuk, Elaine ^b   Chang, Andrew ^c   Kesselheim, Aaron S ^a   Brennan, Troyen A ^c   Choudhry, Niteesh K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c CVS Caremark   (United States)

Author keywords

Dispense as written; Generic; Medication; Prescription

Indexed keywords

GENERIC DRUG;

ADULT; AGE; AGED; ARTICLE; BILLING AND CLAIMS; BIOGEOGRAPHIC REGION; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PHARMACY BENEFIT MANAGER; PRESCRIPTION; PRIORITY JOURNAL;

DRUG SUBSTITUTION; HUMANS; LEGISLATION, DRUG; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; UNITED STATES;

EID: 79952950489     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.11.020     Document Type: Article

References (17)

1. H. Kohl, and W.H. Shrank The role of the government in increasing generic drug use: savings for seniors and Medicare J Am Geriatr Soc 55 2007 1106 1109 (Pubitemid 47024634)
2. A.S. Kesselheim, A.S. Misono, and J.L. Lee The clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis J Am Med Assoc 300 2008 2514 2526
3. J.S. Haas, K.A. Phillips, and E.P. Gerstenberger Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000 Ann Intern Med 142 2005 891 897
4. M.A. Fischer, and J. Avorn Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA 291 2004 1850 1856 (Pubitemid 38509497)
5. W.H. Shrank, N.K. Choudhry, and J. Agnew-Blais State generic substitution laws can lower drug outlays under Medicaid Health Aff. 29 2010 1383 1390
6. W.H. Shrank, E. Cox, M.A. Fischer, J. Mehta, and N.K. Choudhry Patient perceptions of generic medications Health Aff 28 2009 546 556
7. M.J. Berg, R.A. Gross, L.S. Haskins, W.M. Zingaro, and K.J. Tomaszewski Generic substitution in the treatment of epilepsy: patient and physician perceptions Epilepsy Behav 13 2008 693 699
8. National Association of Boards of Pharmacy 2008 State Pharmacy Law and Rules Database Mount Prospect, IL
9. W.H. Shrank, T. Hoang, and S.L. Ettner The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions Arch Intern Med 166 2006 332 337 (Pubitemid 43244321)
10. I. Franceti, L. Lasagna, M. Weintraub, and F.E. Karch Prescription prices under the New York generic substitution law Ann Intern Med 92 1980 419 423
11. E.D. Sumner, A.W. Karig, and H.H. Hunt Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978 Contemp Pharm Pract 5 1982 124 129
12. A.F. Shaughnessy, and R.O. Nickel Prescription-writing patterns and errors in a family medicine residency program J Fam Pract 29 1989 290 295 (Pubitemid 19230500)
13. National Drug Data File Plus (NDDF Plus), 2010; First DataBank, Inc., South San Francisco, CA.
14. State Health Facts. Kaiser Family Foundation http://www.statehealthfacts. org/profileind.jsp?sub=66&rgn=1&cat=5 Accessed July 1, 2010
15. W.H. Shrank, S.M. Cadarette, and E. Cox Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care 47 2009 319 325
16. A.D. Federman, E.A. Halm, C. Zhu, T. Hochman, and A.L. Sui Association of income and prescription drug coverage with generic medication use among older adults with hypertension Am J Manage Care 12 2006 611 618 (Pubitemid 44657341)
17. A.S. Kesselheim, A.S. Misono, and J.L. Lee Seizure outcomes following use of generic vs. brand-name antiepileptic drugs: a systematic review and meta-analysis Drugs 70 2010 605 621